QF
BLCM

QVT Financial’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

QVT Financial’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-30,072
Closed -$3.71M – 83
2017
Q1 		$3.71M Sell
30,072
-3,720
-11% -$487K 0.12% 65
2016
Q4 		$4.6M Sell
33,792
-5,092
-13% -$904K 0.14% 71
2016
Q3 		$7.74M Sell
38,884
-11,910
-23% -$2.05M 0.29% 51
2016
Q2 		$6.58M Hold
50,794
– – 0.45% 52
2016
Q1 		$4.75M Buy
50,794
+16,695
+49% +$1.82M 0.29% 68
2015
Q4 		$6.91M Buy
34,099
+2,325
+7% +$416K 0.39% 57
2015
Q3 		$4.62M Buy
+31,774
New +$5.83M 0.16% 72

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

QVT Financial's BLCM Position: Q2 2017 in Review

QVT Financial sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q2 2017, closing a stake of 30,072 shares — an estimated $3.71M sold.

QVT Financial first reported a position in BLCM in Q3 2015 and held it in 7 quarters. The position peaked at $7.74M in Q3 2016. 84 funds tracked by Wall St. Rank hold BLCM as of Q2 2017.

  • QVT Financial reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
  • QVT Financial sold 30,072 Bellicum Pharmaceuticals, Inc. shares in Q2 2017, an estimated $3.71M.
  • QVT Financial first reported a position in Bellicum Pharmaceuticals, Inc. in Q3 2015 and held it in 7 quarters.
  • QVT Financial's Bellicum Pharmaceuticals, Inc. position peaked at $7.74M in Q3 2016.
  • 84 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2017.

Based on QVT Financial's 13F filing for Q2 2017, filed 14 Aug 2017.